Author:
Li Peng,Song Runjie,Yin Fan,Liu Mei,Liu Huijiao,Ma Shuoqian,Jia Xiaomeng,Lu Xiaohui,Zhong Yuting,Yu Lei,Li Xiru,Li Xiangdong
Funder
National Key Research and Development Program of China
National Natural Science Foundation of China
Beijing Municipal Natural Science Foundation
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference44 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment;Clark;Curr. Probl. Diagn. Radiol.,2015
3. Biology, epidemiology, clinical aspects of hepatocellular carcinoma and the role of sorafenib;Mazzoccoli;Curr. Drug Targets,2016
4. Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma;Li;Cancer Lett.,2016
5. Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion;Xiao;Oncogene,2020
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献